
by Biospring | Apr 26, 2022 | DNA, Drug Development, Drug Discovery, Life Sciences Technology, Proteins, Proteome, Proteomics
Proteomics is the study of proteins (the proteome) in a cell, tissue, or organism. This emerging sector of the life sciences is helping scientists gain a deeper understanding of molecular biology. Proteins are large, complex molecules present in all living organisms....
by Biospring | Apr 25, 2022 | DNA, Drug Development, Drug Discovery, Manufacturing, Pharma, Supply Chain, Sybio, Synthetic Biology
Synthetic biology (synbio) is a life sciences technology that is transforming a broad range of industries including agriculture, chemicals, food, and medicine. Synbio applies engineering principles to biology and uses genomics to “code” organisms to yield a desired...
by Biospring | Apr 25, 2022 | Concentric, COVID-19, DNA, Ginkgo Bioworks, Jason Kelly, Synbio, Synthetic Biology
Ginkgo Bioworks is using its synthetic biology platform in the fight against the pandemic. We asked Jason Kelly, CEO of Ginkgo Bioworks, to update us on Concentric, a program that offers COVID-19 testing at scale to support schools and businesses in their reopening...